Medtronic (MDT) Stock Forecast & Price Target

$87.82 +0.37 (+0.42%)

As of 09:35 AM Eastern

Medtronic - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 16 Analyst Ratings

Sell
0

Hold
8

Buy
8

Based on 16 Wall Street analysts who have issued ratings for Medtronic in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 8 have given a hold rating, 7 have given a buy rating, and 1 has given a strong buy rating for MDT.

Consensus Price Target

$97.00
10.46% Upside

According to the 16 analysts' twelve-month price targets for Medtronic, the average price target is $97.00. The highest price target for MDT is $109.00, while the lowest price target for MDT is $87.00. The average price target represents a forecasted upside of 10.46% from the current price of $87.82.

Get the Latest News and Ratings for MDT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Medtronic and its competitors.

MDT Analyst Ratings Over Time

Type	Current Forecast 6/10/24 to 6/10/25	1 Month Ago 5/11/24 to 5/11/25	3 Months Ago 3/12/24 to 3/12/25	1 Year Ago 6/11/23 to 6/10/24
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	6 Buy rating(s)	6 Buy rating(s)	5 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	8 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$97.00	$96.14	$96.07	$93.00
Forecasted Upside	10.46% Upside	15.18% Upside	4.91% Upside	11.85% Upside
Consensus Rating	Moderate Buy	Hold	Hold	Hold

MDT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MDT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Medtronic Stock vs. The Competition

Type	Medtronic	Medical Companies	S&P 500
Consensus Rating Score	2.56	2.81	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	10.90% Upside	5,918.79% Upside	13.46% Upside
News Sentiment Rating	Positive News See Recent MDT News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
6/6/2025	Needham & Company LLC 2 of 5 stars	Mike Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
5/22/2025	Mizuho 3 of 5 stars	Anthony Petrone Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$100.00 ➝ $98.00	+19.99%
5/22/2025	Royal Bank of Canada 3 of 5 stars	Shagun Singh Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$105.00 ➝ $101.00	+24.10%
5/22/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	David Rescott Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$94.00 ➝ $92.00	+12.71%
4/11/2025	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Richard Newitter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$93.00 ➝ $90.00	+10.25%
3/4/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$92.00 ➝ $107.00	+13.59%
2/19/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Danielle Antalffy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$85.00 ➝ $95.00	+10.40%
11/26/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$105.00 ➝ $109.00	+27.11%
11/20/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$96.00 ➝ $97.00	+15.68%
11/20/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$106.00 ➝ $98.00	+13.95%
Get the Latest News and Ratings for MDT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.
11/15/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$99.00 ➝ $96.00	+9.84%
10/1/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$100.00 ➝ $104.00	+16.16%
8/23/2024	Daiwa America Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Department Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/21/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$85.00 ➝ $90.00	+4.41%
8/21/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$85.00 ➝ $87.00	+1.90%
8/21/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$92.00 ➝ $94.00	+10.10%
5/30/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Sell	$83.00	+1.84%
11/22/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$104.00 ➝ $98.00	+24.68%
6/30/2023	22nd Century Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Initiates
6/30/2023	CL King Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$106.00	+22.16%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 09:24 AM ET.

Should I Buy Medtronic Stock? MDT Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, June 6, 2025. Please send any questions or comments about these Medtronic pros and cons to contact@marketbeat.com.

Medtronic
Bull Case

Here are some ways that investors could benefit from investing in Medtronic plc:

Medtronic plc recently reported strong quarterly earnings, with earnings per share exceeding analysts' expectations, indicating robust financial performance.
The company has increased its quarterly dividend to $0.71 per share, reflecting a commitment to returning value to shareholders and suggesting financial stability.
Analysts have a consensus rating of "Moderate Buy" for Medtronic plc, with an average target price of around $97.00, indicating positive market sentiment.
The stock has shown resilience with a current price around $84.00, which is within a reasonable range compared to its fifty-two week high of $96.25, suggesting potential for growth.
Medtronic plc's revenue has increased by 3.9% compared to the same quarter last year, showcasing its ability to grow in a competitive market.

Medtronic
Bear Case

Investors should be bearish about investing in Medtronic plc for these reasons:

The company's dividend payout ratio is currently at 78.45%, which may indicate that a significant portion of earnings is being distributed to shareholders, potentially limiting funds for reinvestment in growth.
Recent analyst downgrades, including a shift from "buy" to "hold" ratings by some firms, may signal concerns about future performance and market conditions.
Medtronic plc's stock has experienced fluctuations, with a fifty-day moving average price of $84.00, which could suggest volatility and uncertainty in the short term.
Some analysts have reduced their price targets for the stock, indicating a more cautious outlook on its future performance.
The competitive landscape in the medical technology sector is intense, which may pose challenges for Medtronic plc in maintaining its market position and profitability.

MDT Forecast - Frequently Asked Questions

: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Medtronic is $97.00, with a high forecast of $109.00 and a low forecast of $87.00.
: 16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 8 hold ratings, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MDT shares.
: According to analysts, Medtronic's stock has a predicted upside of 10.46% based on their 12-month stock forecasts.
: Medtronic has been rated by research analysts at Mizuho, Needham & Company LLC, Robert W. Baird, Royal Bank of Canada, and Truist Financial in the past 90 days.
: Analysts like Medtronic less than other "medical" companies. The consensus rating score for Medtronic is 2.56 while the average consensus rating score for "medical" companies is 2.81. Learn more on how MDT compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:MDT) was last updated on 6/10/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Medtronic (MDT) Stock Forecast & Price Target